USMLE Reviewer
(By Subscription)
The integrative pathophysiology of atherosclerosis, ischemic heart disease, and the systemic inflammatory response.
Atherosclerosis develops over many years (1) and can lead to myocardial infarction (2), while the stress of acute myocardial infarction (2) also produces an “echo” in atherosclerotic plaques (1). Acute myocardial infarction causes pain and anxiety that triggers sympathetic outflow from the central nervous system (3). β3 adrenergic stimulation mobilizes leukocyte progenitors from their bone marrow niche. These progenitor cells can migrate to the spleen, where they can multiply in response to hematopoietic growth factors. The proinflammatory monocytes then leave the spleen and enter the atherosclerotic plaque (1), where they promote inflammation that can render a plaque more likely to provoke thrombosis and hence acute myocardial infarction (2). IL, interleukin. Reproduced with permission from Libby P, Nahrendorf M, Swirski FK: Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded “Cardiovascular Continuum.” J Am Coll Cardiol. 2016 Mar 8;67(9):1091-1103.192
++++++++++++++Fibrous plaques, or atheromas, occur within the intima of arteries, most frequently the proximal portions of the coronary arteries, the larger branches of the carotid arteries, the circle of Willis, the large vessels of the lower extremities, and the renal and mesenteric arteries (Figure 9.1).
Atherosclerosis is the most frequent cause of significant morbidity caused by vascular disease. It is seen worldwide, but the highest incidence occurs in Finland, Great Britain, other northern European countries, the United States, and Canada.
The incidence is more than 10-fold greater in Finland than that in Japan.
(By Subscription)